CClinicalTrials.gg
CompletedNCT04187326ALPHAUpdated Sep 4, 2025Results posted

Assessing Visual Processing in High Anxiety

An interventional study of Facial Microexpression Training in Anxiety, sponsored by University of Massachusetts, Worcester. Completed at 1 site in United States. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-04.

Sponsored by University of Massachusetts, Worcester · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

High trait anxiety, a stable personality trait, is a risk factor for psychiatric disorders. Individuals with high trait anxiety have difficulty differentiating safety from threat, including visual information like emotional faces. This study aims to characterize visual system function in high trait anxiety. A portion of this study involves an intervention. For the intervention portion, a subset of participants will be asked to return for a lab visit upon completing the first portion of the study (multimodal magnetic resonance imaging (MRI) scan). During this follow up visit, participants will complete a computer task that involves looking at faces and identifying emotions. Participants will complete this task either six months or twelve months after their MRI scan visit. Results from this research have the potential to inform novel therapies that target the visual system in individuals at risk for the development of psychiatric disorders.

Read the detailed description

The purpose of this study is to understand how people with anxious personalities process emotional facial expressions. The intervention portion of this study is part of a larger study. The first portion of this study consists of a screening visit with questionnaires, and a second visit with a magnetic resonance imaging (MRI) scan and short computer tasks.

For the intervention portion of this study, a subset of participants will return to the lab for an in-person visit either six or twelve months after their MRI scan. This visit will last approximately two hours. Participants will be asked to complete a computer task where they will be asked to identify emotional face expressions and receive feedback on their performance. They will also complete questionnaires about their mood and emotions.

The primary purpose of this research is to gather scientific information about how people with anxiety process social and emotional information.

02

Conditions studied

  • Anxiety

Browse trials for

Keywords

  • visual processing
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 23 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University of Massachusetts, Worcester is the lead sponsor of 288 studies on the registry; 54 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 18 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Young adults varying continuously in trait anxiety as assessed by the Spielberger State Trait Anxiety Inventory (STAI).
  • HTA participants with STAI trait scores of ≥44

Exclusion criteria

Exclusion Criteria:

  • contraindication to MRI
  • history of head trauma or loss of consciousness
  • major medical or neurological illness
  • current psychiatric medication usage or use in the last three months
  • alcohol/substance abuse or dependence and/or illicit substance use (excepting cannabis) in the last three months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    6 Month Micro Expression Training Task

    The Micro Expression Training Task (METT) presents videos of subtle emotional face expressions; participants receive real-time feedback following forced choice emotional identification. The METT includes a brief pre-test, training, and then a post-test.

    Behavioral: Facial Microexpression Training

  • Experimental
    12 Month Micro Expression Training Task

    The Micro Expression Training Task (METT) presents videos of subtle emotional face expressions; participants receive real-time feedback following forced choice emotional identification. The METT includes a brief pre-test, training, and then a post-test. Participants in this group will complete this task twelve month after their first visit.

    Behavioral: Facial Microexpression Training

Interventions

  • BehavioralFacial Microexpression Training

    The METT is a well-validated task designed to improve perception of subtle changes in facial expressions, termed microexpressions. Participants with high trait anxiety will return to the lab approximately six months post scan visit to complete this computer-based task. They will receive feedback during the task on their accuracy.

06

What researchers measure

Primary outcomes

  1. Tolerability of the Micro Expression Training Task in Individuals With High Anxiety

    Rates of completion of the behavioral task

    Time frame: six or twelve months post-scan visit

07

Results

Posted Sep 4, 2025

Participant flow

Participant flow — Overall Study
Milestone6 Month Micro Expression Training Task12 Month Micro Expression Training Task
Started78
Completed56
Not completed22
Withdrew: Lost to follow-up21
Withdrew: Computer error- task was only partially completed.01

Outcome measures

PrimaryTolerability of the Micro Expression Training Task in Individuals With High Anxiety

Rates of completion of the behavioral task

Time frame:
six or twelve months post-scan visit
Reported as:
Count of participants · Participants
Tolerability of the Micro Expression Training Task in Individuals With High Anxiety
Participants6 Month Micro Expression Training Task12 Month Micro Expression Training Task
Tolerability of the Micro Expression Training Task in Individuals With High Anxiety56

Adverse events

Collected over 1 year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
6 Month Micro Expression Training Task0/7 (0%)0/7 (0%)0/7 (0%)
12 Month Micro Expression Training Task0/8 (0%)0/8 (0%)0/8 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)6 Month Micro Expression Training Task12 Month Micro Expression Training TaskTotal
<=18 years000
Between 18 and 65 years7815
>=65 years000
Age, Continuous
Age, Continuous(years)6 Month Micro Expression Training Task12 Month Micro Expression Training TaskTotal
Mean25.08 ± 3.0522.91 ± 3.2923.92 ± 3.27
Sex: Female, Male
Sex: Female, Male(Participants)6 Month Micro Expression Training Task12 Month Micro Expression Training TaskTotal
Female5510
Male235
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)6 Month Micro Expression Training Task12 Month Micro Expression Training TaskTotal
Hispanic or Latino101
Not Hispanic or Latino6814
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)6 Month Micro Expression Training Task12 Month Micro Expression Training TaskTotal
American Indian or Alaska Native000
Asian325
Native Hawaiian or Other Pacific Islander000
Black or African American101
White369
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)6 Month Micro Expression Training Task12 Month Micro Expression Training TaskTotal
United States7815
08

Study locations

1 site
  • University of Massachusetts Chan School of Medicine
    Worcester, Massachusetts 01655, United States
09

References and documents

Study documents

  • Study protocol · Apr 26, 2023
  • Informed consent form · Dec 27, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04187326
Lead sponsor
University of Massachusetts, Worcester
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Elliot Kale Edmiston (Associate Professor, University of Massachusetts, Worcester) — Principal investigator
First posted
Dec 5, 2019
Start date
Mar 1, 2021
Primary completion
Mar 15, 2024
Completion
Mar 15, 2024
Results posted
Sep 4, 2025
Last update
Sep 4, 2025

Study contacts

Elliot K Edmiston, PhD
principal investigator · Associate Professor

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion